Search

Your search keyword '"Bressac-de Paillerets, Brigitte"' showing total 396 results

Search Constraints

Start Over You searched for: Author "Bressac-de Paillerets, Brigitte" Remove constraint Author: "Bressac-de Paillerets, Brigitte"
396 results on '"Bressac-de Paillerets, Brigitte"'

Search Results

1. The role of cancer predisposition syndrome in children and adolescents with very rare tumours

2. Biallelic Germline BRCA1 Frameshift Mutations Associated with Isolated Diminished Ovarian Reserve.

3. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

4. The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding.

5. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype–phenotype correlation among 605 entries

6. Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

7. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

8. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families

9. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

10. The role of cancer predisposition syndrome in children and adolescents with very rare tumours

11. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype–phenotype correlation among 605 entries

12. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

13. Supplementary Tables 1-4 from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

14. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

15. Data from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

16. Supplementary Tables 1 - 7 and Figures 1 - 3 from Genetic Evidence of a Precisely Tuned Dysregulation in the Hypoxia Signaling Pathway during Oncogenesis

17. Data from Genetic Evidence of a Precisely Tuned Dysregulation in the Hypoxia Signaling Pathway during Oncogenesis

18. Supplementary Data from Genetic Evidence of a Precisely Tuned Dysregulation in the Hypoxia Signaling Pathway during Oncogenesis

19. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

20. PARKIN Inactivation Links Parkinson’s Disease to Melanoma

22. Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma

24. Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I

27. The CDKN2A/p16INK4a 5′UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

29. A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

30. A germline mutation in PBRM1 predisposes to renal cell carcinoma

31. Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma

32. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

33. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

34. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

36. Germline Mutations of Inhibins in Early-Onset Ovarian Epithelial Tumors

37. Identification of a novel CTNNA1 germline mutation predisposing to melanoma: Genotype and functional effects.

38. The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma

40. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

41. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort (vol 46, pg 7913, 2018)

42. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants

43. Tracking of Second Primary Melanomas in Vemurafenib-Treated Patients

44. Localization of a novel melanoma susceptibility locus to 1p22

45. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

46. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

47. Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma

48. Characteristics of the coexistence of melanoma and renal cell carcinoma

49. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

50. Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Catalog

Books, media, physical & digital resources